Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Linagliptin;   Drug: Acarbose Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials